You are here

Pfizer

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak

Fierce Biotech

Wed, 08/7/24 - 11:19 am

antibody-drug conjugate

Pfizer to create 500 new jobs as it upgrades Australia manufacturing plant to help fight antimicrobial resistance

Fierce Pharma

Tue, 08/6/24 - 05:59 pm

antimicrobial resistance

drug manufacturing

Ex-Pfizer drug reduces osteoarthritis pain in British biotech's phase 2 study

Fierce Biotech

Tue, 08/6/24 - 11:16 am

Pfizer, GSK and Moderna execs remain optimistic about RSV vaccines despite CDC blowback

Pharma Voice

Tue, 08/6/24 - 11:13 am

Moderna Therapeutics

Big Pharma-Backed Ribon Therapeutics Shuts Down Business Operations

BioSpace

Mon, 08/5/24 - 11:21 am

Ribon Therapeutics

PARP inhibitors

RSV Vaccine Makers Hit Hard by New CDC Guidelines

BioSpace

Sun, 08/4/24 - 06:35 pm

Moderna Therapeutics

Pfizer’s Bourla confident in company’s obesity drug position, despite delays

Pharma Voice

Thu, 08/1/24 - 11:14 am

Despite Late-Stage Hemophilia Win, Sangamo Remains in Do-or-Die Situation

BioSpace

Wed, 07/31/24 - 10:48 am

Sangamo BioSciences

3 Big Pharma cancer drugs facing inflation penalties

Pharma Voice

Wed, 07/31/24 - 10:27 am

Inflation Reduction Act

Bristol Myers Squibb

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

CNBC

Tue, 07/30/24 - 11:55 am

Pfizer takes $230M hit after axing failed DMD gene therapy—and tosses out RSV combo vaccine

Fierce Biotech

Tue, 07/30/24 - 11:50 am

RSV vaccine makers vying for market share in second year of shots

Reuters

Mon, 07/29/24 - 10:44 pm

Moderna Therapeutics

Prediction: This Will Be Pfizer's Next Big Move

Motley Fool

Mon, 07/29/24 - 10:43 am

Pfizer quickly expands its hemophilia B gene therapy's reach with EU approval

Fierce Pharma

Thu, 07/25/24 - 10:02 pm

Pfizer says hemophilia gene therapy meets late-stage study goal

BioPharma Dive

Wed, 07/24/24 - 11:53 am

clinical trials

giroctocogene fitelparvovec

Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.

Motley Fool

Sun, 07/21/24 - 11:02 pm

Pfizer's ATTR heart disease drug needs hefty discount, says ICER draft report. What about Alnylam's Amvuttra?

Fierce Pharma

Fri, 07/19/24 - 11:36 am

Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason

Reuters

Wed, 07/17/24 - 09:17 pm

artificial intelligence

Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering

Fierce Biotech

Fri, 07/12/24 - 11:14 am

Viking Therapeutics

Terns Pharmaceuticals

Pages